Skip to main content
OpenTrials

Clinical trial condition

Interstitial Lung Disease

Explore clinical trials studying Interstitial Lung Disease. Study availability and eligibility vary by location and protocol.

208 public trials 67 recruiting studies
Refine in advanced search Browse all conditions

Interstitial Lung Disease trial results

Recruiting

Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CT

NCT06743022

Conditions
Interstitial Lung Disease, Lung Diseases, Lung Diseases, Interstitial, +1 more
Locations
  • APHP - Bichat hospital - Radiology Paris, IDF, France
  • APHP - Bichat hospital - Rheumatology Paris, IDF, France
  • APHP - Cochin Hospital - Internal medicine Paris, IDF, France
  • APHP - Cochin Hospital - Pneumology Paris, IDF, France
View Trial Details
Recruiting

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

NCT06855329

Conditions
Interstitial Lung Disease, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Massachusetts Chan Medical School Worcester, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Texas Southwestern Dallas, Texas, United States
  • University of Virginia Charlottesville, Virginia, United States
View all 13 locations
View Trial Details
Recruiting

FAPI PET for Lung Fibrosis

NCT05365802

Conditions
Alveolitis, Extrinsic Allergic, Drug-Induced Pneumonitis, Fibrosis, +20 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View Trial Details
Recruiting

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

NCT06247397

Conditions
Chronic Obstructive Pulmonary Disease Severe, Chronic Respiratory Failure With Hypoxia, Interstitial Lung Disease, +3 more
Locations
  • Research Unit, Blekinge University of Technology Karlskrona, Blekinge County, Sweden
  • Department of Heart, Lung and Clinical Physiology, Örebro University Hospital Örebro, Sweden
View Trial Details
Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

NCT05892614

Conditions
Connective Tissue Diseases, Fibrosis, Infections, +11 more
Locations
  • aTyr Investigative Site Los Angeles, California, United States
  • aTyr Investigative Site San Diego, California, United States
  • aTyr Investigative Site Miami, Florida, United States
  • aTyr Investigative Site Chicago, Illinois, United States
View all 15 locations
View Trial Details

Related conditions